These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8505874)

  • 1. Diffusion- and T2-weighted imaging: evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil.
    Seega J; Elger B
    Magn Reson Imaging; 1993; 11(3):401-9. PubMed ID: 8505874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
    Elger B; Seega J; Raschack M
    Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats.
    Elger B; Seega J; Brendel R
    Stroke; 1994 Sep; 25(9):1836-41. PubMed ID: 8073466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levemopamil injection after cerebral oligemia reduces spatial memory deficits in rats.
    Heim C; Sieklucka M; Sontag KH
    Pharmacol Biochem Behav; 1994 Jul; 48(3):613-9. PubMed ID: 7938114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI).
    Walberer M; Stolz E; Müller C; Friedrich C; Rottger C; Blaes F; Kaps M; Fisher M; Bachmann G; Gerriets T
    Lab Anim; 2006 Jan; 40(1):1-8. PubMed ID: 16460584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
    Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
    Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.
    Yenari MA; Palmer JT; Sun GH; de Crespigny A; Mosely ME; Steinberg GK
    Brain Res; 1996 Nov; 739(1-2):36-45. PubMed ID: 8955922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ca2+ channel and 5-HT2 receptor antagonist (s)-emopamil in cerebral ischaemia.
    Defeudis FV
    Trends Pharmacol Sci; 1989 Jun; 10(6):215-7. PubMed ID: 2672461
    [No Abstract]   [Full Text] [Related]  

  • 12. (S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat.
    Nakayama H; Ginsberg MD; Dietrich WD
    Neurology; 1988 Nov; 38(11):1667-73. PubMed ID: 3185899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation.
    Huang YC; Tzeng WS; Wang CC; Cheng BC; Chang YK; Chen HH; Lin PC; Huang TY; Chuang TJ; Lin JW; Chang CP
    Magn Reson Imaging; 2013 Sep; 31(7):1174-81. PubMed ID: 23642800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats.
    Gomi S; Greenberg JH; Croul S; Reivich M
    J Neurol Sci; 1995 Jun; 130(2):128-33. PubMed ID: 8586975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists for reduction of brain damage in stroke.
    Sauter A; Rudin M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S43-7. PubMed ID: 1695302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with dizocilpine and levemopamil does not reduce ischemic neuronal injury in rats.
    Sano T; Patel PM; Drummond JC; Cole DJ
    J Neurosurg Anesthesiol; 1993 Jul; 5(3):194-201. PubMed ID: 8400759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.
    Chandra S; White RF; Everding D; Feuerstein GZ; Coatney RW; Sarkar SK; Barone FC
    Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levemopamil reduces spatial learning deficit following transient occlusion of common carotid arteries in normotensive rats.
    Block F; Szabo L; Jaspers RM; Heim C; Sontag KH
    Acta Neurol Scand; 1993 Jul; 88(1):35-40. PubMed ID: 8372627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Lenhard SC; Strittmatter R; Price WJ; Chandra S; White RF; Barone FC
    Pharmacology; 2008; 81(1):1-10. PubMed ID: 17726342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.